Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 21.5B 3.22B 2.93B 2.71B 2.44B 4.61B 303B 4.78B 32.55B 12.9B 162B 12.1B 11.84B 515B P/E 2026 *
16.6x
P/E 2027 * 14.1x
Enterprise Value 19.67B 2.95B 2.68B 2.48B 2.24B 4.22B 277B 4.37B 29.79B 11.8B 149B 11.07B 10.84B 471B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 1.72x
Free-Float
47.06%
Yield 2026 *
2.56%
Yield 2027 * 3.07%
1 day+2.93%
1 week+0.70%
Current month+4.12%
1 month+2.49%
3 months-6.13%
6 months-1.71%
Current year-4.51%
1 week 13.77
Extreme 13.77
14.52
1 month 13.48
Extreme 13.48
14.59
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.24
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 07/05/2024
Director of Finance/CFO 49 08/07/2018
Chief Investment Officer 45 30/04/2025
Director TitleAgeSince
Director/Board Member 72 01/06/2021
Chairman 54 09/08/2026
Director/Board Member 59 07/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.93%+0.70%-8.46%-1.98% 3.22B
-0.82%+1.40%+39.64%+143.17% 1,275B
-1.12%+0.16%+44.21%+88.24% 680B
-0.16%+0.43%+26.76%+113.01% 521B
-0.56%+1.47%+41.96%+71.59% 389B
-2.23%-2.89%+55.47%+41.64% 356B
-0.77%+0.25%+27.45%+60.31% 305B
-0.98%+0.13%+2.28%+35.50% 287B
-0.72%-0.63%+37.29%+71.87% 250B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.47%+0.62%+30.06%+74.82% 428B
Weighted average by Cap. -0.86%+0.76%+36.50%+97.46%

Financials

2026 *2027 *
Net sales 8.52B 1.28B 1.16B 1.07B 969M 1.83B 120B 1.89B 12.9B 5.11B 64.39B 4.8B 4.69B 204B 9.2B 1.38B 1.25B 1.16B 1.05B 1.97B 130B 2.04B 13.93B 5.52B 69.51B 5.18B 5.07B 220B
Net income 1.29B 194M 176M 163M 147M 278M 18.23B 288M 1.96B 776M 9.78B 728M 713M 30.99B 1.52B 229M 208M 192M 173M 327M 21.46B 339M 2.31B 914M 11.52B 858M 840M 36.48B
Net Debt -1.82B -274M -249M -230M -208M -392M -25.7B -405M -2.76B -1.09B -13.79B -1.03B -1.01B -43.68B -5.68B -851M -773M -715M -645M -1.22B -79.93B -1.26B -8.59B -3.4B -42.89B -3.19B -3.13B -136B
Projected Income Statement - Annual - Tasly Pharmaceutical Group Co., Ltd
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
16/11/26 CN¥14.39 +2.93% 21,853,322
13/11/26 CN¥13.98 +0.14% 10,524,160
12/11/26 CN¥13.96 -0.14% 13,026,320
11/11/26 CN¥13.98 -1.27% 9,529,058
10/11/26 CN¥14.16 -0.91% 9,113,100
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Tasly Pharmaceutical Group Co., Ltd
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
14.39CNY
Average target price
16.73CNY
Spread / Average Target
+16.28%
  1. Stock Market
  2. Stocks
  3. 600535 Stock